Premium
Tocilizumab therapy in individuals with COVID ‐19 infection and hyperinflammatory state
Author(s) -
McCarthy Cormac,
Savinelli Stefano,
Feeney Eoin R.,
Butler Marcus W.,
O'Broin Cathal,
Ryan Silke,
O'Neill Lorraine,
Murphy David J.,
Gallagher Charles G.,
McKone Edward F.,
Waqas Sarmad,
Cotter Aoife,
Doran Peter,
Keane Michael P.,
Mallon Patrick W.
Publication year - 2020
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/resp.13912
Subject(s) - medicine , tocilizumab , covid-19 , virology , immunology , rheumatoid arthritis , outbreak , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom